366 related articles for article (PubMed ID: 25278343)
1. Involvement of L-arginine/NO/cGMP/K(ATP) channel pathway in the peripheral antinociceptive actions of ellagic acid in the rat formalin test.
Ghorbanzadeh B; Mansouri MT; Hemmati AA; Naghizadeh B; Mard SA; Rezaie A
Pharmacol Biochem Behav; 2014 Nov; 126():116-21. PubMed ID: 25278343
[TBL] [Abstract][Full Text] [Related]
2. Local antinociceptive action of fluoxetine in the rat formalin assay: role of l-arginine/nitric oxide/cGMP/K
Ghorbanzadeh B; Mansouri MT; Naghizadeh B; Alboghobeish S
Can J Physiol Pharmacol; 2018 Feb; 96(2):165-172. PubMed ID: 28787580
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the L-arginine/Nitric Oxide/Cyclic GMP/KATP Channel Pathway and PPARγ Receptors in the Peripheral Antinociceptive Effect of Carbamazepine.
Ghorbanzadeh B; Kheirandish V; Mansouri MT
Drug Res (Stuttg); 2019 Dec; 69(12):650-657. PubMed ID: 31272117
[TBL] [Abstract][Full Text] [Related]
4. The role of l -arginine/NO/cGMP/K ATP channel pathway in the local antinociceptive effect of berberine in the rat formalin test.
Rahemi M; Mohtadi S; Rajabi Vardanjani H; Khodayar MJ
Behav Pharmacol; 2023 Dec; 34(8):449-456. PubMed ID: 36939560
[TBL] [Abstract][Full Text] [Related]
5. Tingenone, a pentacyclic triterpene, induces peripheral antinociception due to NO/cGMP and ATP-sensitive K(+) channels pathway activation in mice.
de Carvalho Veloso C; Rodrigues VG; Ferreira RC; Duarte LP; Klein A; Duarte ID; Romero TR; de Castro Perez A
Eur J Pharmacol; 2015 May; 755():1-5. PubMed ID: 25748602
[TBL] [Abstract][Full Text] [Related]
6. Role of l-arginine/SNAP/NO/cGMP/K
Safaripour S; Nemati Y; Parvardeh S; Ghafghazi S; Fouladzadeh A; Moghimi M
J Pharm Pharmacol; 2018 Apr; 70(4):507-515. PubMed ID: 29380385
[TBL] [Abstract][Full Text] [Related]
7. Possible activation of the NO-cyclic GMP-protein kinase G-K+ channels pathway by gabapentin on the formalin test.
Ortiz MI; Medina-Tato DA; Sarmiento-Heredia D; Palma-Martínez J; Granados-Soto V
Pharmacol Biochem Behav; 2006 Mar; 83(3):420-7. PubMed ID: 16630650
[TBL] [Abstract][Full Text] [Related]
8. Noradrenaline activates the NO/cGMP/ATP-sensitive K(+) channels pathway to induce peripheral antinociception in rats.
Romero TR; Guzzo LS; Perez AC; Klein A; Duarte ID
Nitric Oxide; 2012 Mar; 26(3):157-61. PubMed ID: 22330728
[TBL] [Abstract][Full Text] [Related]
9. Ang-(1-7) activates the NO/cGMP and ATP-sensitive K+ channels pathway to induce peripheral antinociception in rats.
Costa A; Galdino G; Romero T; Silva G; Cortes S; Santos R; Duarte I
Nitric Oxide; 2014 Feb; 37():11-6. PubMed ID: 24361899
[TBL] [Abstract][Full Text] [Related]
10. Central and peripheral antinociceptive effects of ellagic acid in different animal models of pain.
Taghi Mansouri M; Naghizadeh B; Ghorbanzadeh B; Farbood Y
Eur J Pharmacol; 2013 May; 707(1-3):46-53. PubMed ID: 23528359
[TBL] [Abstract][Full Text] [Related]
11. Additive antinociceptive effect of the combination of diazoxide, an activator of ATP-sensitive K+ channels, and sodium nitroprusside and dibutyryl-cGMP.
Alves DP; Soares AC; Francischi JN; Castro MS; Perez AC; Duarte ID
Eur J Pharmacol; 2004 Apr; 489(1-2):59-65. PubMed ID: 15063156
[TBL] [Abstract][Full Text] [Related]
12. L-NAME causes antinociception by stimulation of the arginine-NO-cGMP pathway.
Duarte ID; Ferreira SH
Mediators Inflamm; 2000; 9(1):25-30. PubMed ID: 10877451
[TBL] [Abstract][Full Text] [Related]
13. Probable activation of the opioid receptor-nitric oxide-cyclic GMP-K+ channels pathway by codeine.
Ortiz MI; Castro-Olguín J; Peña-Samaniego N; Castañeda-Hernández G
Pharmacol Biochem Behav; 2005 Dec; 82(4):695-703. PubMed ID: 16386786
[TBL] [Abstract][Full Text] [Related]
14. Participation of the opioid receptor - nitric oxide - cGMP - K
Ortiz MI; Cariño-Cortés R; Castañeda-Hernández G
Can J Physiol Pharmacol; 2020 Nov; 98(11):753-762. PubMed ID: 33095677
[TBL] [Abstract][Full Text] [Related]
15. Involvement of opioid receptors in the systemic and peripheral antinociceptive actions of ellagic acid in the rat formalin test.
Mansouri MT; Naghizadeh B; Ghorbanzadeh B
Pharmacol Biochem Behav; 2014 May; 120():43-9. PubMed ID: 24561064
[TBL] [Abstract][Full Text] [Related]
16. Montelukast, a cysteinyl leukotriene receptor antagonist, exerts local antinociception in animal model of pain through the L-arginine/nitric oxide/cyclic GMP/K
Alizamani E; Ghorbanzadeh B; Naserzadeh R; Mansouri MT
Int J Neurosci; 2021 Oct; 131(10):1004-1011. PubMed ID: 32408781
[TBL] [Abstract][Full Text] [Related]
17. Possible participation of the nitric oxide-cyclic GMP-protein kinase G-K+ channels pathway in the peripheral antinociception of melatonin.
Hernández-Pacheco A; Araiza-Saldaña CI; Granados-Soto V; Mixcoatl-Zecuatl T
Eur J Pharmacol; 2008 Oct; 596(1-3):70-6. PubMed ID: 18755181
[TBL] [Abstract][Full Text] [Related]
18. The anti-nociceptive activity of naringenin passes through L-arginine/NO/cGMP/KATP channel pathway and opioid receptors.
Moradi N; Fakhri S; Farzaei MH; Abbaszadeh F
Behav Pharmacol; 2021 Oct; 32(7):590-598. PubMed ID: 34483246
[TBL] [Abstract][Full Text] [Related]
19. The synthetic peptide PnPP-19 induces peripheral antinociception via activation of NO/cGMP/K
Freitas AC; Silva GC; Pacheco DF; Pimenta AM; Lemos VS; Duarte ID; de Lima ME
Nitric Oxide; 2017 Apr; 64():31-38. PubMed ID: 28087360
[TBL] [Abstract][Full Text] [Related]
20. The Nitric oxide/CGMP/KATP pathway mediates systemic and central antinociception induced by resistance exercise in rats.
Galdino GS; Xavier CH; Almeida R; Silva G; Fontes MA; Menezes G; Duarte ID; Perez AC
Int J Neurosci; 2015; 125(10):765-73. PubMed ID: 25271801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
